Mitochondria and Iron: current questions

• Published in: Expert review of hematology Vol. 10; no. 1; p. 65
• Main Authors: Paul, Bibbin T, Manz, David H, Torti, Frank M, Torti, Suzy V
• Format: Journal Article
• Language: English
• Published: England 02.01.2017
• Subjects: Animals; Biological Transport; Carrier Proteins - metabolism; Disease Susceptibility; Heme - biosynthesis; Humans; Iron - metabolism; Mitochondria - metabolism; Neoplasms - metabolism; Neoplasms - pathology; Protein Binding; Sulfur - metabolism; iron trafficking; Iron; cancer; heme synthesis; iron-sulfur cluster; mitochondria
• ISSN: 1747-4094
• DOI: 10.1080/17474086.2016.1268047

Mitochondria are cellular organelles that perform numerous bioenergetic, biosynthetic, and regulatory functions and play a central role in iron metabolism. Extracellular iron is taken up by cells and transported to the mitochondria, where it is utilized for synthesis of cofactors essential to the function of enzymes involved in oxidation-reduction reactions, DNA synthesis and repair, and a variety of other cellular processes. Areas covered: This article reviews the trafficking of iron to the mitochondria and normal mitochondrial iron metabolism, including heme synthesis and iron-sulfur cluster biogenesis. Much of our understanding of mitochondrial iron metabolism has been revealed by pathologies that disrupt normal iron metabolism. These conditions affect not only iron metabolism but mitochondrial function and systemic health. Therefore, this article also discusses these pathologies, including conditions of systemic and mitochondrial iron dysregulation as well as cancer. Literature covering these areas was identified via PubMed searches using keywords: Iron, mitochondria, Heme Synthesis, Iron-sulfur Cluster, and Cancer. References cited by publications retrieved using this search strategy were also consulted. Expert commentary: While much has been learned about mitochondrial and its iron, key questions remain. Developing a better understanding of mitochondrial iron and its regulation will be paramount in developing therapies for syndromes that affect mitochondrial iron.